| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,669 |
4,271 |
$472K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,556 |
4,120 |
$305K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
516 |
516 |
$48K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
93 |
92 |
$37K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
113 |
113 |
$16K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
47 |
47 |
$15K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
23 |
23 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
763 |
741 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
32 |
32 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
31 |
31 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
49 |
49 |
$791.37 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
16 |
$682.97 |
| 99335 |
|
75 |
75 |
$567.06 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
31 |
30 |
$547.74 |
| 90756 |
|
15 |
15 |
$300.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
16 |
$272.01 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$216.50 |